atDose

Yokohama, Japan · Founded 2017 · Privately Held (backing)

Developer of a mobile dosing and infusion device designed to change the treatment methods for serious illnesses. atDose is based in Yokohama, Japan and was founded in 2017. Its last reported valuation was $36.9 million in Dec 2024. It has raised $4.1 million.

Last reported valuation
$36.9M
Oct 2026
Priced at
—
Total raised
$4.1M
Last round
—
Team — not yet on record

No current team members for atDose are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of atDose with a free account
  • ·Watch atDose: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View